Original article
Natural history and outcomes of MASLD and MetALD following non-alcoholic fatty liver disease reclassification in a Canadian cohort
Yousef Almahannaa, Francisco Idalsoagaa,b, Luis Antonio Díazb,c, Ahmed Almohsena, Yi Nong Songa, Amani Bajunayda, Rokhsana Mortuzaa, Jeemin Kima, Adrienne Abayaa, Mohammad Qasim Khana,d,
, Juan Pablo Arabb,e,**
Corresponding author
qasim.khan@lhsc.on.ca
Correspondence authors at. Division of Gastroenterology and Hepatology, Western University & London Health Sciences Centre, 339 Windermere Road, University Hospital, London, Ontario N6A 5A5, Canada.
Correspondence authors at. Division of Gastroenterology and Hepatology, Western University & London Health Sciences Centre, 339 Windermere Road, University Hospital, London, Ontario N6A 5A5, Canada.
Corresponding author
JuanPablo.Arab@vcuhealth.org
Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, 1200 E. Broad St, 14th floor, PO Box 980341, Richmond, VA 23298, USA.
Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, 1200 E. Broad St, 14th floor, PO Box 980341, Richmond, VA 23298, USA.
a Division of Gastroenterology and Hepatology, Western University & London Health Sciences Centre, London, Canada
b Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica De Chile, Santiago, Chile
c MASLD Research Center, Division of Gastroenterology and Hepatology, University of California San Diego, La Jolla, CA, USA
d Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada
e Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA, USA
